We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSYS icon
3851
Nortech Systems
NSYS
$33.8M
$11K ﹤0.01%
822
-100
-11% -$1.24K
OEC icon
3852
Orion
OEC
$364M
$11K ﹤0.01%
630
-4,528
-88% -$76.1K
ONCO icon
3853
Onconetix
ONCO
$2.99M
0
OPBK icon
3854
OP Bancorp
OPBK
$233M
$11K ﹤0.01%
978
+956
+4,345% +$11K
PD icon
3855
PagerDuty
PD
$918M
$11K ﹤0.01%
422
-49,172
-99% -$1.16M
PEBO icon
3856
Peoples Bancorp
PEBO
$1.49B
$11K ﹤0.01%
405
-4,128
-91% -$121K
PETS icon
3857
PetMed Express
PETS
$38.9M
$11K ﹤0.01%
660
-5,570
-89% -$111K
PGRE
3858
DELISTED
Paramount Group
PGRE
$11K ﹤0.01%
1,899
-31,341
-94% -$196K
PLXS icon
3859
Plexus
PLXS
$7.13B
$11K ﹤0.01%
99
-3,729
-97% -$377K
RDNT icon
3860
RadNet
RDNT
$6.01B
$11K ﹤0.01%
585
-5,214
-90% -$97.5K
RDUS
3861
DELISTED
Radius Recycling
RDUS
$11K ﹤0.01%
380
-1,749
-82% -$54K
RMTI icon
3862
Rockwell Medical
RMTI
$29.2M
$11K ﹤0.01%
1,124
+352
+46% +$3.77K
SEB icon
3863
Seaboard Corp
SEB
$4.18B
$11K ﹤0.01%
3
-3
-50% -$11.3K
SGMA
3864
DELISTED
Sigmatron International
SGMA
$11K ﹤0.01%
3,052
+343
+13% +$1.65K
SLGL icon
3865
Sol-Gel Technologies
SLGL
$277M
$11K ﹤0.01%
243
-321
-57% -$15.2K
SNDA icon
3866
Sonida Senior Living
SNDA
$1.88B
$11K ﹤0.01%
881
-619
-41% -$9.3K
SONN
3867
DELISTED
Sonnet BioTherapeutics
SONN
$11K ﹤0.01%
53
+29
+121% +$6.35K
SPRU icon
3868
Spruce Power Holding Corp
SPRU
$33.8M
$11K ﹤0.01%
+1,496
New +$10.6K
STRO icon
3869
Sutro Biopharma
STRO
$340M
$11K ﹤0.01%
134
-191
-59% -$13.3K
TARS icon
3870
Tarsus Pharmaceuticals
TARS
$3.04B
$11K ﹤0.01%
742
-748
-50% -$12.4K
TAYD icon
3871
Taylor Devices
TAYD
$178M
$11K ﹤0.01%
784
-72
-8% -$874
TFSL icon
3872
TFS Financial
TFSL
$4.95B
$11K ﹤0.01%
739
-4,242
-85% -$58K
TR icon
3873
Tootsie Roll Industries
TR
$3.08B
$11K ﹤0.01%
290
-1,174
-80% -$42.8K
TRT
3874
Trio-Tech International
TRT
$116M
$11K ﹤0.01%
4,568
+966
+27% +$2.35K
TTGT icon
3875
TechTarget
TTGT
$278M
$11K ﹤0.01%
247
-1,857
-88% -$97.3K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.